Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium

Author： Antoine C.   Ameye L.   Moreau M.   Paesmans M.   Rozenberg S.  

Publisher： Informa Healthcare

ISSN： 1473-0804

Source： Climacteric, Vol.14, Iss.4, 2011-08, pp. : 464-471

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The truth about hormone replacement therapy and breast cancer

By Priyadarshi Sewanti   Fernandez Imelyn M   Voige Hayley   Del Priore Giuseppe  

Expert Review of Obstretrics and Gynecology, Vol. 2, Iss. 1, 2007-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Hormone replacement therapy and cancer

By Genazzani A. R.   Gadducci A.   Gambacciani M.  

Climacteric, Vol. 4, Iss. 3, 2001-09 ,pp. : 181-193

Informa Healthcare

Access to resources Recommend Favorite

Impact of menopausal hormone. Replacement therapy on prognostic characteristics of breast cancer.

By Bonnier P.   Sakr R.   Bessenay F.   Lejeune C.   Charpin C.   Martin P.M.   Piana L.  

Gynecology Obstetrique & Fertilite, Vol. 28, Iss. 10, 2000-10 ,pp. : 745-753

Elsevier

Access to resources Recommend Favorite

Does hormone replacement therapy increase the risk of breast cancer?

By Lecuru F.   Laforest H.   Darles C.   Taurelle R.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 62, Iss. 2, 1995-10 ,pp. : 159-166

Elsevier

Access to resources Recommend Favorite

Hormone replacement therapy and breast cancer morbidity, mortality and recurrence

By Kenemans P.   Scheele F.   Burger C.W.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 71, Iss. 2, 1997-02 ,pp. : 199-203

Elsevier

Access to resources Recommend Favorite